ArticlebioRxiv : the preprint server for biology2026

Allogeneic CRISPR-Engineered CAR-T Cells Drive Potent Antitumor Activity in Solid Tumors.

Mingyu Huo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.